Ian E. James
About
Ian E. James is a scholar working on Molecular Biology, Rheumatology and Oncology.
According to data from OpenAlex, Ian E. James has authored 53 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 21 papers in Rheumatology and 16 papers in Oncology. Recurrent topics in Ian E. James's work include Bone Metabolism and Diseases (19 papers), Bone health and treatments (11 papers) and Bone and Dental Protein Studies (11 papers). Ian E. James is often cited by papers focused on Bone Metabolism and Diseases (19 papers), Bone health and treatments (11 papers) and Bone and Dental Protein Studies (11 papers). Ian E. James collaborates with scholars based in United States, United Kingdom and Australia. Ian E. James's co-authors include Robert A. Dodds, Maxine Gowen, Michael W. Lark, Janice R. Connor, Edward R. Appelbaum, Edward Dul, Simon Blake, David J. Rieman, John C. Lee and Keith C. Deen and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Blood.
In The Last Decade
Ian E. James
53 papers receiving 4.3k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ian E. James United States | 30 | 2.7k | 1.3k | 1.3k | 708 | 570 | 53 | 4.4k | ||
| Gregg Wesolowski United States | 29 | 2.3k 0.9× | 1.7k 1.3× | 1.4k 1.1× | 539 0.8× | 212 0.4× | 49 | 4.5k | ||
| Ling Qin United States | 39 | 2.1k 0.8× | 1.4k 1.0× | 1.1k 0.9× | 479 0.7× | 293 0.5× | 131 | 4.5k | ||
| Noriyoshi Kurihara United States | 37 | 2.4k 0.9× | 2.2k 1.7× | 664 0.5× | 494 0.7× | 449 0.8× | 106 | 4.3k | ||
| Patricia Collin‐Osdoby United States | 27 | 2.0k 0.7× | 1.3k 1.0× | 423 0.3× | 365 0.5× | 476 0.8× | 38 | 3.4k | ||
| Gabriel Mbalaviele United States | 35 | 2.7k 1.0× | 816 0.6× | 664 0.5× | 499 0.7× | 715 1.3× | 78 | 4.2k | ||
| Takuhiko Akatsu Japan | 32 | 4.5k 1.7× | 3.4k 2.6× | 932 0.7× | 735 1.0× | 724 1.3× | 54 | 6.3k | ||
| Leonard Rifas United States | 27 | 1.7k 0.6× | 941 0.7× | 630 0.5× | 341 0.5× | 423 0.7× | 49 | 3.5k | ||
| Peter L. E. M. van Lent Netherlands | 43 | 2.3k 0.9× | 833 0.6× | 3.0k 2.3× | 894 1.3× | 1.8k 3.2× | 129 | 6.1k | ||
| Jean Michel Foidart Belgium | 32 | 1.2k 0.4× | 1.3k 1.0× | 601 0.5× | 936 1.3× | 494 0.9× | 70 | 4.1k | ||
| Saeid M. Seyedin United States | 30 | 2.7k 1.0× | 1.1k 0.8× | 830 0.7× | 329 0.5× | 142 0.2× | 42 | 4.3k |
Countries citing papers authored by Ian E. James
Since
Specialization
Citations
This map shows the geographic impact of Ian E. James's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian E. James with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian E. James more than expected).
Fields of papers citing papers by Ian E. James
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Ian E. James. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian E. James. The network helps show where Ian E. James may publish in the future.
Co-authorship network of co-authors of Ian E. James
This figure shows the co-authorship network connecting the top 25 collaborators of Ian E. James. A scholar is included among the top collaborators of Ian E. James based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian E. James. Ian E. James is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Soergel, David G., Ruth Ann Subach, Nancy Burnham, et al.. (2014). Biased agonism of the μ-opioid receptor by TRV130 increases analgesia and reduces on-target adverse effects versus morphine: A randomized, double-blind, placebo-controlled, crossover study in healthy volunteers. Pain. 155(9). 1829–1835.
2.
Soergel, David G., Ruth Ann Subach, Ian E. James, et al.. (2013). TRVO27, A BETA-ARRESTIN BIASED LIGAND AT THE ANGIOTENSIN 2 TYPE 1 RECEPTOR, PRODUCES RAPID, REVERSIBLE CHANGES IN HEMODYNAMICS IN PATIENTS WITH STABLE SYSTOLIC HEART FAILURE. Journal of the American College of Cardiology. 61(10). E683–E683.
3.
Ort, Tatiana, Ian E. James, Peter J. Bugelski, et al.. (2011). A Novel EPO Receptor Agonist Improves Glucose Tolerance via Glucose Uptake in Skeletal Muscle in a Mouse Model of Diabetes. Experimental Diabetes Research. 2011. 1–10.
4.
Bugelski, Peter J., Renold J. Capocasale, Deborah Marshall, et al.. (2008). CNTO 530: Molecular pharmacology in human UT-7EPO cells and pharmacokinetics and pharmacodynamics in mice. Journal of Biotechnology. 134(1-2). 171–180.
5.
Bugelski, Peter J., et al.. (2007). Pharmacodynamics of Recombinant Human Erythropoietin in Murine Bone Marrow. Pharmaceutical Research. 25(2). 369–378.
6.
Kumar, Sanjay, Lauren Dare, Janice A. Vasko-Moser, et al.. (2006). A highly potent inhibitor of cathepsin K (relacatib) reduces biomarkers of bone resorption both in vitro and in an acute model of elevated bone turnover in vivo in monkeys. Bone. 40(1). 122–131.
7.
James, Ian E., Robert W. Marquis, Simon Blake, et al.. (2001). Potent and Selective Cathepsin L Inhibitors Do Not Inhibit Human Osteoclast Resorption in Vitro. Journal of Biological Chemistry. 276(15). 11507–11511.
8.
Rieman, David J., Robert A. Dodds, Shing Mei Hwang, et al.. (2001). Biosynthesis and processing of cathepsin K in cultured human osteoclasts. Bone. 28(3). 282–289.
9.
Gowen, Maxine, George B. Stroup, Robert A. Dodds, et al.. (2000). Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic rats. Journal of Clinical Investigation. 105(11). 1595–1604.
10.
James, Ian E., Sanjay Kumar, Michael R. Barnes, et al.. (2000). FrzB-2: a human secreted frizzled-related protein with a potential role in chondrocyte apoptosis. Osteoarthritis and Cartilage. 8(6). 452–463.
11.
Connor, J.R., Robert A. Dodds, Ian E. James, et al.. (2000). Differential expression of Egr-1 in osteoarthritic compared to normal adult human articular cartilage. Osteoarthritis and Cartilage. 8(3). 161–169.
12.
Votta, Bartholomew J., John R. White, Robert A. Dodds, et al.. (2000). CK?-8 [CCL23], a novel CC chemokine, is chemotactic for human osteoclast precursors and is expressed in bone tissues. Journal of Cellular Physiology. 183(2). 196–207.
13.
Loening, Andreas M., Ian E. James, Marc E. Levenston, et al.. (2000). Injurious Mechanical Compression of Bovine Articular Cartilage Induces Chondrocyte Apoptosis. Archives of Biochemistry and Biophysics. 381(2). 205–212.
14.
Kumar, Sanjay, Janice R. Connor, Robert A. Dodds, et al.. (1999). Identification and Cloning of a Connective Tissue Growth Factor-like cDNA from Human Osteoblasts Encoding a Novel Regulator of Osteoblast Functions. Journal of Biological Chemistry. 274(24). 17123–17131.
15.
Prabhakar, Uma, Ian E. James, Robert A. Dodds, et al.. (1998). A Novel Human Bone Marrow Stroma-Derived Cell Line TF274 Is Highly Osteogenic In Vitro and In Vivo. Calcified Tissue International. 63(3). 214–220.
16.
Emery, John G., Peter McDonnell, Keith C. Deen, et al.. (1998). Osteoprotegerin Is a Receptor for the Cytotoxic Ligand TRAIL. Journal of Biological Chemistry. 273(23). 14363–14367.
17.
Belfiore, Pietro, Ian E. James, Denise Zembryki, et al.. (1998). (2Z,4E)-5-(5,6-dichloro-2-indolyl)-2-methoxy-N-(1,2,2,6,6-pentamethylpiperidin-4-yl)-2,4-pentadienamide, a novel, potent and selective inhibitor of the osteoclast V-ATPase. Bioorganic & Medicinal Chemistry Letters. 8(24). 3621–3626.
18.
Drake, Fred H., Robert A. Dodds, Ian E. James, et al.. (1996). Cathepsin K, but Not Cathepsins B, L, or S, Is Abundantly Expressed in Human Osteoclasts. Journal of Biological Chemistry. 271(21). 12511–12516.
19.
Connor, J.R., Robert A. Dodds, Ian E. James, & Maxine Gowen. (1995). Human osteoclast and giant cell differentiation: the apparent switch from nonspecific esterase to tartrate resistant acid phosphatase activity coincides with the in situ expression of osteopontin mRNA.. Journal of Histochemistry & Cytochemistry. 43(12). 1193–1201.
20.
James, Ian E., Susan Walsh, Robert A. Dodds, & Maxine Gowen. (1991). Production and characterization of osteoclast-selective monoclonal antibodies that distinguish between multinucleated cells derived from different human tissues.. Journal of Histochemistry & Cytochemistry. 39(7). 905–914.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Gregg Wesolowski Breakdown of academic impact, for papers by Ling Qin Breakdown of academic impact, for papers by Noriyoshi Kurihara Breakdown of academic impact, for papers by Patricia Collin‐Osdoby Breakdown of academic impact, for papers by Gabriel Mbalaviele Breakdown of academic impact, for papers by Takuhiko Akatsu Breakdown of academic impact, for papers by Leonard Rifas Breakdown of academic impact, for papers by Peter L. E. M. van Lent Breakdown of academic impact, for papers by Jean Michel Foidart Breakdown of academic impact, for papers by Saeid M. Seyedin